Molecular pathological analysis of the occurrence and progress of pancreatic carcinoma in situ using biopsy/pancreatic juice specimen.

Molecular pathological analysis of the occurrence and progress of pancreatic carcinoma in situ using biopsy/pancreatic juice specimen. - Analysis of the progress of pancreatic carcinoma in situ.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048934

Enrollment

Registered

2022-09-14

Start date

2022-07-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic carcinoma in situ Small pancreatic ductal adenocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with suspicious pancreatic carcinoma in situ and who undergo pancreatic juice cytology.

Exclusion criteria

Exclusion criteria: cannot obtain consensus. cannot obtain sufficient pancreatic juice. cannot undergo surgically resection

Design outcomes

Primary

Measure	Time frame
Analysis of the molecular pathological factor effecting the progress of pancreatic carcinoma in situ.	—

Countries

Japan

Contacts

Public ContactRyota Sagami

Oita University Faculty of Medicine Department of Gastroenterology

sagami1985@yahoo.co.jp097-549-4411

Outcome results